Preliminary scientific tests reveal conolidine could inhibit unique ion channels, lessening neuronal excitability and limiting discomfort signals. This mechanism is especially related in neuropathic suffering, in which irregular signaling will cause persistent soreness. In addition, conolidine seems to impact G protein-coupled receptor (GPCR) pathw